The full tool, for when you already know your vial size and how much water you want to use. If you would rather be walked through it one question at a time, start here instead.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 200 mcg | daily | 0.12 mL | 12 u | 14 | 2.8 mg |
| Weeks 3–4 | 250 mcg | daily | 0.15 mL | 15 u | 14 | 3.5 mg |
| Week 5 onward per 4 weeks from here on |
500 mcg | daily | 0.3 mL | 30 u | 28 | 14 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Low reported | 200 mcg | 1× daily | 0.12 mL | 12 u | 25 doses |
| Commonly reported | 250 mcg | 1–2× daily | 0.15 mL | 15 u | 20 doses |
| Upper reported | 500 mcg | 1–2× daily | 0.3 mL | 30 u | 10 doses |
| Research study dose | 10 mcg/kg | daily, 7–21 d | Set by body weight — can't be turned into a single amount to draw | ||
A pentadecapeptide fragment derived from a sequence in human gastric juice. The published record is almost entirely preclinical research on tendon, ligament, muscle and gastrointestinal healing. There is no completed, published human efficacy trial, and reported doses are extrapolations from weight-based research figures rather than clinically established ranges.
Buy BPC-157Paid affiliate links.